{"transactions":[{"id":745995,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T20:20:35.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":41600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 4, 2027, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":219054,"source":{"system":"sec-edgar","filing":"0001193125-26-261800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000119312526261800/ownership.xml","form_type":"4"}},{"id":1117679,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T21:35:30.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":59225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":177454,"source":{"system":"sec-edgar","filing":"0000950170-25-083888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000095017025083888/ownership.xml","form_type":"4"}},{"id":1506978,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-21T20:53:30.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":37578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":37578,"derivative":{"exercise_price":5.48,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":37578},"source":{"system":"sec-edgar","filing":"0000950170-24-063019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000095017024063019/ownership.xml","form_type":"4"}},{"id":1506977,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T20:53:30.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":20529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":118229,"source":{"system":"sec-edgar","filing":"0000950170-24-063019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000095017024063019/ownership.xml","form_type":"4"}},{"id":1858559,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:18:16.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":33960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":33960,"derivative":{"exercise_price":6.5,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":33960},"source":{"system":"sec-edgar","filing":"0001209191-23-036280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919123036280/doc4.xml","form_type":"4"}},{"id":1858558,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T20:18:16.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":17307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":97700,"source":{"system":"sec-edgar","filing":"0001209191-23-036280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919123036280/doc4.xml","form_type":"4"}},{"id":2225208,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T20:54:28.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":24707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":24707,"derivative":{"exercise_price":9.37,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":24707},"source":{"system":"sec-edgar","filing":"0001209191-22-038447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919122038447/doc4.xml","form_type":"4"}},{"id":2225207,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T20:54:28.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":12006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":80393,"source":{"system":"sec-edgar","filing":"0001209191-22-038447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919122038447/doc4.xml","form_type":"4"}},{"id":2247204,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T20:47:19.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in 12 equal monthly installments beginning on July 14, 2012."}],"balance_after":0,"derivative":{"exercise_price":4.15,"expiration_date":"2022-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-033561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919122033561/doc4.xml","form_type":"4"}},{"id":2247203,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:47:19.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":6500,"price":9.8542,"value":64052.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price of the stock options, which were scheduled to expire June 13, 2022 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":68387,"source":{"system":"sec-edgar","filing":"0001209191-22-033561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919122033561/doc4.xml","form_type":"4"}},{"id":2247202,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:47:19.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":15000,"price":4.15,"value":62250.0,"ownership":{"direct":true},"balance_after":74887,"source":{"system":"sec-edgar","filing":"0001209191-22-033561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919122033561/doc4.xml","form_type":"4"}},{"id":2669929,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T20:35:19.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":19.21,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-040237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919121040237/doc4.xml","form_type":"4"}},{"id":2669928,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T20:35:19.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":59887,"source":{"system":"sec-edgar","filing":"0001209191-21-040237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919121040237/doc4.xml","form_type":"4"}},{"id":2849453,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T01:43:04.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in 12 equal monthly installments beginning on July 16, 2011."}],"balance_after":0,"derivative":{"exercise_price":7.11,"expiration_date":"2021-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-012204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919121012204/doc4.xml","form_type":"4"}},{"id":2849452,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T01:43:04.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":5754,"price":18.5372,"value":106663.0488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price of the stock options, which were scheduled to expire June 15, 2021 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":54887,"source":{"system":"sec-edgar","filing":"0001209191-21-012204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919121012204/doc4.xml","form_type":"4"}},{"id":2849451,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T01:43:04.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":15000,"price":7.11,"value":106650.0,"ownership":{"direct":true},"balance_after":60641,"source":{"system":"sec-edgar","filing":"0001209191-21-012204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919121012204/doc4.xml","form_type":"4"}},{"id":3110354,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T23:11:07.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":10.57,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-036782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919120036782/doc4.xml","form_type":"4"}},{"id":3110353,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T23:11:07.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":45641,"source":{"system":"sec-edgar","filing":"0001209191-20-036782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919120036782/doc4.xml","form_type":"4"}},{"id":3130374,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2020-05-29T20:10:50.000Z","date":"2020-05-28","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in 12 equal monthly installments beginning on July 3, 2010."}],"balance_after":0,"derivative":{"exercise_price":7.38,"expiration_date":"2020-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-032896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919120032896/doc4.xml","form_type":"4"}},{"id":3130373,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T20:10:50.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":10129,"price":11.0382,"value":111805.9278,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire June 2, 2020 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.99 to $11.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":40641,"source":{"system":"sec-edgar","filing":"0001209191-20-032896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919120032896/doc4.xml","form_type":"4"}},{"id":3130372,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T20:10:50.000Z","date":"2020-05-28","kind":"exercise","acquired":true,"shares":15000,"price":7.38,"value":110700.0,"ownership":{"direct":true},"balance_after":50770,"source":{"system":"sec-edgar","filing":"0001209191-20-032896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919120032896/doc4.xml","form_type":"4"}},{"id":3427217,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2019-08-28T20:30:16.000Z","date":"2019-08-26","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in 12 equal monthly installments beginning on September 27, 2009."}],"balance_after":0,"derivative":{"exercise_price":14.78,"expiration_date":"2019-08-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-047610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919119047610/doc4.xml","form_type":"4"}},{"id":3427216,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-28T20:30:16.000Z","date":"2019-08-26","kind":"sale","acquired":false,"shares":15000,"price":14.85,"value":222750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold to cover the payment of the option exercise price (which represents 99.94% of the proceeds from the sales made by the Reporting Person) of the option, which was set to expire on August 26, 2019."}],"balance_after":35770,"source":{"system":"sec-edgar","filing":"0001209191-19-047610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919119047610/doc4.xml","form_type":"4"}},{"id":3427215,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-28T20:30:16.000Z","date":"2019-08-26","kind":"exercise","acquired":true,"shares":15000,"price":14.78,"value":221700.0,"ownership":{"direct":true},"balance_after":50770,"source":{"system":"sec-edgar","filing":"0001209191-19-047610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919119047610/doc4.xml","form_type":"4"}},{"id":3487513,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T21:03:00.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 13, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":15.04,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-037411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919119037411/doc4.xml","form_type":"4"}},{"id":3487512,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T21:03:00.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU).  100% of the shares subject to this RSU will vest on June 13, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":35770,"source":{"system":"sec-edgar","filing":"0001209191-19-037411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919119037411/doc4.xml","form_type":"4"}},{"id":3892269,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T20:31:21.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 13, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":18.3,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-016771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000089924318016771/doc4.xml","form_type":"4"}},{"id":3892268,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T20:31:21.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 13, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":30770,"source":{"system":"sec-edgar","filing":"0000899243-18-016771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000089924318016771/doc4.xml","form_type":"4"}},{"id":3987369,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-20T21:02:37.000Z","date":"2018-03-19","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vested in 12 equal monthly installments beginning on June 8, 2008."}],"balance_after":0,"derivative":{"exercise_price":4.98,"expiration_date":"2018-05-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-020921","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919118020921/doc4.xml","form_type":"4"}},{"id":3987368,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-20T21:02:37.000Z","date":"2018-03-19","kind":"exercise","acquired":true,"shares":15000,"price":4.98,"value":74700.0,"ownership":{"direct":true},"balance_after":25770,"source":{"system":"sec-edgar","filing":"0001209191-18-020921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919118020921/doc4.xml","form_type":"4"}},{"id":4277265,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-19T21:08:29.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 15, 2018, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":13.75,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-040881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919117040881/doc4.xml","form_type":"4"}},{"id":4277264,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40435,"kind":"person","name":"DUGAN RICHARD W","position":1,"cik":"0001263499","reported_name":"DUGAN RICHARD W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-19T21:08:29.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU).  100% of the shares subject to this RSU will vest on June 15, 2018, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10770,"source":{"system":"sec-edgar","filing":"0001209191-17-040881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263499/000120919117040881/doc4.xml","form_type":"4"}}]}